Clinical Trials Browser

Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE × 90 days × Clear all

NCT07313202 2025-12-31

Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance

Phase 2 Not yet recruiting

Other solid neoplasm

Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE